Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
Stay abreast of the latest trends in psychopharmacology, from the over-the-counter availability of Naloxone to the deadly rise of Xylazine and the ongoing tension between federal and state marijuana laws.
Psychiatry September 27th 2023
American Journal of Endocannabinoid Medicine (AJEM)
Learn more about how the HHS’s recommendation to reschedule marijuana could revolutionize research and impact your practice, offering more comprehensive treatment options for patients.
Family Medicine/General Practice September 6th 2023
Epoch Health
New research reveals elevated levels of toxic heavy metals in marijuana users, highlighting the need for physicians to consider this when treating patients with conditions that may be impacted by heavy metal exposure.
This longitudinal study offers valuable insights into the complex effects of medical cannabis on quality of life in anxiety patients. Physicians may find the nuanced findings on mental and physical well-being particularly relevant for treatment considerations.
Family Medicine/General Practice August 30th 2023
Mayo Clinic Labs
Discover how Mayo Clinic’s new lab test can enhance your ability to accurately distinguish between new and residual marijuana use, thereby informing better clinical and legal decisions.
Northwestern Medicine
Discover the pioneering research connecting marijuana use with modifications in the human epigenome. The study brings to light potential health implications and illuminates areas for future exploration.
Psychiatry July 26th 2023